The objective of the MAGBBRIS Project is to enhance ischemic tissue remodelling by encapsulating EPCs-secretome into biocompatible nanocapsules labelled with  magnetic nanoparticles and fluorescent tags, allowing magnetic guidance and retention, simultaneous in vivo imaging and controlled release.

LATEST NEWS

MAGBBRIS is funded within the framework of the EuroNanoMed III Joint Transnational Call
by the following National Founding Agencies:

Euronanomed3 logo

July 16, 2019

During the 15-16th of July 2019, Fabien Gosselet from the blood-brain barrier laboratory of Artois University, welcomed the rest of the MAGBBRIS project members in the beautiful Jean Perrin faculty in Lens, France. 

This...

May 28, 2019

During late May 2019, Euronanomed hosted in Bratislava a Review Seminar for projects funded in the 2015, 2016 and 2017 joint Calls. Of course, MAGBBRIS project had it's representation on it: consortium coordinator Anna R...

Please reload

CONSORTIUM PARTNERS

MAGBBRIS is a highly multidisciplinary consortium integrated by 6 partners from 5 European countries, involved in materials-science, biomedical and clinical research and industrial partnership. 

CONTACT US

UPCOMING EVENTS

​Teleconference

7th of May 2019

​Euronanomed Symposium

Bratislava, SK

28-29th of May 2019

​Teleconference

4th of June 2019

​MAGBBRIS Annual Meeting

Lens, FR

15-16h of July 2019